Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G S Firestein

Showing results (81-90 of 117) with videos related to

Pageof 12
Sort By:
The Journal of Physiology|April 16, 2016
Cellular electrophysiological principles that modulate secretion from synovial fibroblastsR B Clark, T A Schmidt, F B Sachse, et al.
The Journal of Rheumatology|April 27, 2000
Empirical advantages of adeno associated viral vectors in vivo gene therapy for arthritisJ Goater, R Müller, G Kollias, et al.
The Journal of Rheumatology|June 19, 1998
Direct synovial gene transfer with retroviral vectors in rat adjuvant arthritisK H Nguyen, D L Boyle, J E McCormack, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1992
Alpha 4/beta 1 integrin (VLA-4) ligands in arthritis. Vascular cell adhesion molecule-1 expression in synovium and on fibroblast-like synoviocytesJ Morales-Ducret, E Wayner, M J Elices, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 1999
NF-kappa B regulation by I kappa B kinase in primary fibroblast-like synoviocytesK R Aupperle, B L Bennett, D L Boyle, et al.
Gene Therapy|January 19, 2000
Intra-articular IL-4 gene therapy in arthritis: anti-inflammatory effect and enhanced th2activityD L Boyle, K H Nguyen, S Zhuang, et al.
The Journal of Experimental Medicine|November 1, 1988
Cytokines in chronic inflammatory arthritis. I. Failure to detect T cell lymphokines (interleukin 2 and interleukin 3) and presence of macrophage colony-stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid synovitisG S Firestein, W D Xu, K Townsend, et al.
Annals of the Rheumatic Diseases|July 24, 2007
Assessment of rituximab's immunomodulatory synovial effects (ARISE trial). 1: clinical and synovial biomarker resultsA Kavanaugh, S Rosengren, S J Lee, et al.
The Journal of Clinical Investigation|July 4, 2001
c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritisZ Han, D L Boyle, L Chang, et al.
The Journal of Rheumatology|October 23, 1997
Alternatively spliced CS-1 fibronectin isoform and its receptor VLA-4 in rheumatoid arthritis synoviumU Müller-Ladner, M J Elices, J B Kriegsmann, et al.
Pageof 12

Showing results (81-90 of 117) with videos related to

Sort By:
Pageof 12
The Journal of Physiology|April 16, 2016
Cellular electrophysiological principles that modulate secretion from synovial fibroblastsR B Clark, T A Schmidt, F B Sachse, et al.
The Journal of Rheumatology|April 27, 2000
Empirical advantages of adeno associated viral vectors in vivo gene therapy for arthritisJ Goater, R Müller, G Kollias, et al.
The Journal of Rheumatology|June 19, 1998
Direct synovial gene transfer with retroviral vectors in rat adjuvant arthritisK H Nguyen, D L Boyle, J E McCormack, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1992
Alpha 4/beta 1 integrin (VLA-4) ligands in arthritis. Vascular cell adhesion molecule-1 expression in synovium and on fibroblast-like synoviocytesJ Morales-Ducret, E Wayner, M J Elices, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 1999
NF-kappa B regulation by I kappa B kinase in primary fibroblast-like synoviocytesK R Aupperle, B L Bennett, D L Boyle, et al.
Gene Therapy|January 19, 2000
Intra-articular IL-4 gene therapy in arthritis: anti-inflammatory effect and enhanced th2activityD L Boyle, K H Nguyen, S Zhuang, et al.
The Journal of Experimental Medicine|November 1, 1988
Cytokines in chronic inflammatory arthritis. I. Failure to detect T cell lymphokines (interleukin 2 and interleukin 3) and presence of macrophage colony-stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid synovitisG S Firestein, W D Xu, K Townsend, et al.
Annals of the Rheumatic Diseases|July 24, 2007
Assessment of rituximab's immunomodulatory synovial effects (ARISE trial). 1: clinical and synovial biomarker resultsA Kavanaugh, S Rosengren, S J Lee, et al.
The Journal of Clinical Investigation|July 4, 2001
c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritisZ Han, D L Boyle, L Chang, et al.
The Journal of Rheumatology|October 23, 1997
Alternatively spliced CS-1 fibronectin isoform and its receptor VLA-4 in rheumatoid arthritis synoviumU Müller-Ladner, M J Elices, J B Kriegsmann, et al.
Pageof 12